Search company, investor...
Forever Labs company logo

Forever Labs

Founded Year



Loan | Alive

Total Raised


Last Raised

$250K | 3 yrs ago

About Forever Labs

Forever Labs operates as a healthcare laboratory. It is a stem cell lab that collects stem cells, cryogenically freezes them, safely stores them in a food and drug administration (FDA)-compliant clinical-grade biorepository, and stores them until the user needs them to combat age-related diseases with advanced therapies. It was founded in 2015 and is based in Ann Arbor, Michigan.

Headquarters Location

206 South Main Street

Ann Arbor, Michigan, 48104,

United States


Missing: Forever Labs's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Forever Labs's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Forever Labs

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Forever Labs is included in 1 Expert Collection, including Regenerative Medicine.


Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

Forever Labs Patents

Forever Labs has filed 7 patents.

The 3 most popular patent topics include:

  • Cell biology
  • Clusters of differentiation
  • Small nuclear RNA
patents chart

Application Date

Grant Date


Related Topics




Clusters of differentiation, Transcription factors, Cell biology, Stem cells, MicroRNA


Application Date


Grant Date



Related Topics

Clusters of differentiation, Transcription factors, Cell biology, Stem cells, MicroRNA



Latest Forever Labs News

Forever Labs to Utilize Data Collection Platform DataBiologics

Sep 14, 2021

09/14/2021 | 09:28am EDT Message : *Required fields ANN ARBOR, Mich., Sept. 14, 2021 (GLOBE NEWSWIRE) --   Forever Labs , the parent company of  SuperShot® PRP , will utilize DataBiologics to track outcomes for their innovative PRP process that allows autologous extracellular vesicles to be isolated. Physicians who already collect, review and analyze data related to their orthobiologic treatment outcomes via the DataBiologics platform, can now include SuperShot® PRP procedures in their data. This newly collected data can then be compared to outcomes for standard PRP procedures. By using DataBiologics, Forever Labs is ensuring that the safety and efficacy of SuperShot® PRP are tracked and monitored, a top priority for the Forever Labs team. "We developed SuperShot® PRP to give clinicians the ability to add autologous extracellular vesicles to their PRP therapies. We are excited to be using DataBiologics to track results. Like them, we believe the best way to forward medicine is to measure and track outcomes with high fidelity." - Steven Clausnitzer, ### Forever Labs is passionate about providing autologous, science-based solutions to improve life quality, along with the most cutting-edge solutions for our partner physicians. SuperShot® PRP is founded on this principle. This innovative PRP process is based on a two-phase aqueous system which allows for the concentration of autologous extracellular vesicles (EVs) from the PPP portion of a PRP procedure in a quick, one-minute spin at benchtop centrifuge speeds. The isolated EVs can then be added back to the PRP fraction for the most complete PRP on the market. "At DataBiologics we believe that there is nothing more important than studying the safety and efficacy of orthobiologic treatments. We are extremely pleased to add the SuperShot® PRP device to the DataBiologics platform. Our goal has always been to offer an easy-to-use patient-reported outcomes platform to the orthobiologics industry. Coupled with the excellent product and device breadth within the platform, we will now be able to offer data tracking on SuperShot® PRP to all participating providers utilizing our platform." - Nancy Ho,

Forever Labs Frequently Asked Questions (FAQ)

  • When was Forever Labs founded?

    Forever Labs was founded in 2015.

  • Where is Forever Labs's headquarters?

    Forever Labs's headquarters is located at 206 South Main Street, Ann Arbor.

  • What is Forever Labs's latest funding round?

    Forever Labs's latest funding round is Loan.

  • How much did Forever Labs raise?

    Forever Labs raised a total of $2.37M.

  • Who are the investors of Forever Labs?

    Investors of Forever Labs include Paycheck Protection Program, Timothy Davis, Silicon Badia, Northwestern Mutual Capital, Aaron Hirschhorn and 6 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.